Vitamin B1 deficiency
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
at-risk asymptomatic hospitalized adults
thiamine
All asymptomatic adults at high risk of vitamin B1 deficiency should be considered for 3 days of high-dose intravenous thiamine.
Although rare, anaphylaxis and anaphylactoid reactions can occur when thiamine is given parenterally.[1]Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun;41(6):1357-424. https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00066-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35365361?tool=bestpractice.com [13]Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 Dec;17(12):1408-18. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2010.03153.x http://www.ncbi.nlm.nih.gov/pubmed/20642790?tool=bestpractice.com It is therefore recommended that intravenous thiamine is administered in the hospital (with facilities for cardiopulmonary resuscitation).[7]Polegato BF, Pereira AG, Azevedo PS, et al. Role of thiamin in health and disease. Nutr Clin Pract. 2019 Aug;34(4):558-64. http://www.ncbi.nlm.nih.gov/pubmed/30644592?tool=bestpractice.com
Refeeding can be a risk factor for precipitating Wernicke encephalopathy. Thiamine should be given before initiating oral, enteral, or parental feeding (including intravenous dextrose therapy) in patients identified as being at risk for refeeding syndrome.[20]da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020 Apr;35(2):178-95. https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10474 http://www.ncbi.nlm.nih.gov/pubmed/32115791?tool=bestpractice.com
There are insufficient data from randomized controlled trials to recommend standard doses for the treatment of vitamin B1 deficiency.[67]Day E, Bentham PW, Callaghan R, et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013 Jul 1;(7):CD004033. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004033.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23818100?tool=bestpractice.com Dosing regimens are therefore based on consensus expert opinion. An example of a suitable dose regimen is presented here.[1]Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun;41(6):1357-424. https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00066-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35365361?tool=bestpractice.com However, dose regimens vary and you should consult your local guidelines or drug information source for more information.
Primary options
thiamine (vitamin B1): 100 mg intravenously three times daily
magnesium, potassium, and/or phosphate replacement
Treatment recommended for SOME patients in selected patient group
Magnesium, potassium, and phosphate levels should be measured and replacement therapy initiated per standard protocols.[20]da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020 Apr;35(2):178-95. https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10474 http://www.ncbi.nlm.nih.gov/pubmed/32115791?tool=bestpractice.com
adult on alcohol withdrawal program
thiamine
Prophylactic oral thiamine should be offered to patients who misuse alcohol before and during medically assisted alcohol withdrawal.[66]National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis and management of physical complications. Apr 2017 [internet publication]. https://www.nice.org.uk/guidance/CG100
Refeeding can be a risk factor for precipitating Wernicke encephalopathy. Thiamine should be given before initiating oral, enteral, or parental feeding (including intravenous dextrose therapy) in patients identified as being at risk for refeeding syndrome.[20]da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020 Apr;35(2):178-95. https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10474 http://www.ncbi.nlm.nih.gov/pubmed/32115791?tool=bestpractice.com
There are insufficient data from randomized controlled trials to recommend standard doses for the treatment of vitamin B1 deficiency.[67]Day E, Bentham PW, Callaghan R, et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013 Jul 1;(7):CD004033. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004033.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23818100?tool=bestpractice.com Dosing regimens are therefore based on consensus expert opinion. An example of a suitable dose regimen is presented here.[1]Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun;41(6):1357-424. https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00066-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35365361?tool=bestpractice.com However, dose regimens vary and you should consult your local guidelines or drug information source for more information.
Primary options
thiamine (vitamin B1): 100-200 mg orally once daily for 3-5 days
More thiamine (vitamin B1)May also be given intravenously; consult your local guidelines.
symptomatic adults
thiamine
High-dose intravenous thiamine should be given for 3 days and the clinical response assessed.
If there is evidence of clinical improvement, intravenous thiamine should be continued at a lower dose for a further 5 days, or until clinical improvement ceases.
If there is no clinical improvement, high-dose intravenous thiamine should be discontinued. Oral thiamine may be continued at lower doses in these patients.
Although rare, anaphylaxis and anaphylactoid reactions can occur when thiamine is given parenterally.[1]Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun;41(6):1357-424. https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00066-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35365361?tool=bestpractice.com [13]Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 Dec;17(12):1408-18. https://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2010.03153.x http://www.ncbi.nlm.nih.gov/pubmed/20642790?tool=bestpractice.com It is therefore recommended that intravenous thiamine is administered in the hospital (with facilities for cardiopulmonary resuscitation).[7]Polegato BF, Pereira AG, Azevedo PS, et al. Role of thiamin in health and disease. Nutr Clin Pract. 2019 Aug;34(4):558-64. http://www.ncbi.nlm.nih.gov/pubmed/30644592?tool=bestpractice.com
Refeeding can be a risk factor for precipitating Wernicke encephalopathy. Thiamine should be given before initiating oral, enteral, or parenteral feeding (including intravenous dextrose therapy) in patients identified as being at risk for refeeding syndrome.[20]da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020 Apr;35(2):178-95. https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10474 http://www.ncbi.nlm.nih.gov/pubmed/32115791?tool=bestpractice.com
There are insufficient data from randomized controlled trials to recommend standard doses for the treatment of vitamin B1 deficiency.[67]Day E, Bentham PW, Callaghan R, et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013 Jul 1;(7):CD004033. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004033.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23818100?tool=bestpractice.com Dosing regimens are therefore based on consensus expert opinion. Examples of suitable dose regimens are presented here and depend on the indication.[1]Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun;41(6):1357-424. https://www.clinicalnutritionjournal.com/article/S0261-5614(22)00066-8/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35365361?tool=bestpractice.com However, dose regimens vary and you should consult your local guidelines or drug information source for more information.
Primary options
thiamine (vitamin B1): Wernicke encephalopathy: 200-500 mg intravenously three times daily for 2-7 days, followed by 250 mg once daily for 3-5 days; berberi: 100-200 mg intravenously three times daily for 2-3 days followed by maintenance therapy; other cause of proven deficiency: 200 mg intravenously three times daily; refeeding syndrome: 300 mg intravenously before initiating nutrition therapy, followed by 200-300 mg once daily for at least 3 days; maintenance therapy: 50-100 mg orally once daily
magnesium, potassium, and/or phosphate replacement
Treatment recommended for SOME patients in selected patient group
Magnesium, potassium, and phosphate levels should also be measured and replacement therapy initiated per standard protocols.[20]da Silva JSV, Seres DS, Sabino K, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020 Apr;35(2):178-95. https://aspenjournals.onlinelibrary.wiley.com/doi/10.1002/ncp.10474 http://www.ncbi.nlm.nih.gov/pubmed/32115791?tool=bestpractice.com
symptomatic children and infants
thiamine
There are no established doses for thiamine replacement in children with symptomatic vitamin B1 deficiency, but it may be appropriate to treat young children with the same dosing regimen as that given to infants.
Infants (both breast-fed and bottle-fed) with symptomatic vitamin B1 deficiency should be treated with a slow intravenous infusion of thiamine followed by 7 days of intramuscular thiamine; 3-6 weeks of oral therapy should then be given.
Intravenous dose is given by slow infusion to reduce risk of anaphylaxis.
There are insufficient data from randomized controlled trials to recommend standard doses for the treatment of vitamin B1 deficiency.[67]Day E, Bentham PW, Callaghan R, et al. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol. Cochrane Database Syst Rev. 2013 Jul 1;(7):CD004033. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004033.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23818100?tool=bestpractice.com Dosing regimens are therefore based on consensus expert opinion. However, dose regimens vary and you should consult your local guidelines or drug information source for more information.
Primary options
thiamine (vitamin B1): consult specialist for guidance on dose
treatment of mother
Treatment recommended for SOME patients in selected patient group
In cases of breast-fed infants with vitamin B1 deficiency, the mother should also be treated with 7 weeks of oral thiamine.[68]World Health Organization; United Nations High Commissioner for Refugees. Thiamine deficiency and its prevention and control in major emergencies. 1999 [internet publication]. https://www.who.int/publications/i/item/WHO-NHD-99.13
Primary options
thiamine (vitamin B1): 10 mg orally once daily for 7 days, followed by 3-5 mg orally once daily for 6 weeks
thiamine-fortified formula milk
Treatment recommended for SOME patients in selected patient group
Bottle-fed infants should receive formula milk fortified with thiamine in addition to the above thiamine supplementation.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer